Compare EPIX Therapeutics vs NeoChord
Customers evaluate the quality of EPIX Therapeutics's products using the following success metrics.
Overview
EPIX Therapeutics is 17 yrs old and is based in United States.
EPIX Therapeutics is a medical device company. It designs and manufactures a catheter-based system for the treatment of patients with cardiac arrhythmias and atrial fibrillation. EPIX Therapeutics was formerly known as Advanced Cardiac Therapeutics. The company was founded in 2007 and is based in Santa Clara, California. In Jan 2019, EPIX Therapeutics was acquired by Medtronic.
NeoChord is 17 yrs old and is based in United States.
NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.
Demo Video
Leadership
Eric Kanowsky (Founder)
John Seaberg (Founder)
Investors
Medtronic, New Enterprise Associates
Treo Venture, Deerfield Management
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because EPIX Therapeutics has not claimed their profile.
Work for EPIX Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for EPIX Therapeutics?
Claim your profile now.
Information not available because NeoChord has not claimed their profile.
Work for NeoChord? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for NeoChord?
Claim your profile now.